About

Nima Aghdam is a radiation oncologist whose research centers on stereotactic body radiation therapy (SBRT) for prostate and lung cancers, with a particular focus on treatment optimization and patient quality of life. His major contributions include pioneering work on five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation (32 citations), demonstrating that re-irradiation with SBRT can achieve reasonable local control in this challenging clinical scenario. Aghdam has also advanced prostate cancer treatment by investigating the use of iodinated SpaceOAR Vue™ during robotic prostate SBRT to spare the rectum, and by exploring testosterone recovery as a biomarker for quality of life following androgen deprivation therapy and SBRT. His work on testosterone kinetics and patient-reported outcomes has helped clarify the relationship between hormonal recovery and improvements in sexual and hormonal domain scores. Additionally, Aghdam has examined management strategies for isolated local failures after prostate SBRT and evaluated IMRT with SBRT boost as a less-invasive alternative to brachytherapy for unfavorable prostate cancer, with five-year outcomes showing promise. His research consistently bridges technical innovation with meaningful improvements in patient experience.

Research Focus

Key Achievements

5
H-Index
7
Papers
63
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation
32 citations · 2017
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 43
🏛 Institutions: Georgetown University, Mayo Clinic in Arizona, Beth Israel Deaconess Medical Center, University of Pennsylvania

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago